A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Conditions
- Acute Myeloid Leukemia Refractory
- Acute Myeloid Leukemia, in Relapse
Interventions
- BIOLOGICAL: Cytokine Induced Memory-Like Natural Killer Cells
- BIOLOGICAL: Atezolizumb
- BIOLOGICAL: CIML-NK cell therapy
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators